HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term Outcome of Zonal Outer Retinopathy in Punctate Inner Choroidopathy or Multifocal Choroiditis.

Abstract
Purpose: To report the long-term prognosis of punctate inner choroidopathy (PIC) or multifocal choroiditis (MFC) and associated zonal outer retinopathy (ZOR).Method: Retrospective study in patients with PIC/MFC and ZOR with a clinical follow-up of 4 years or longer.Results: There were 14 patients in this study (M: F = 11:3). All patients received systemic steroid therapy. The initial and final median logarithm of minimal angle of resolution of BCVA were 1.00 and 0.22 (p = .002). Ellipsoid zone recovery was noted in all patients. The median visual field loss improved from -6.38 dB to -3.41 dB (p = .035). The median of total area of PIC/MFC lesions enlarged from 6.82 mm2 to 8.77 mm2 (p = .005). Recurrent disease was noted in 4 eyes and maintenance steroid was needed in 3 eyes.Conclusion: With steroid therapy, most patients with PIC/MFC and ZOR had good visual prognosis.
AuthorsSan-Ni Chen, Yi-Ling Chen, Benjamin Chi-Lan Yang
JournalOcular immunology and inflammation (Ocul Immunol Inflamm) Vol. 29 Issue 5 Pg. 865-870 (Jul 04 2021) ISSN: 1744-5078 [Electronic] England
PMID31906767 (Publication Type: Journal Article)
Chemical References
  • Coloring Agents
  • Glucocorticoids
  • Indocyanine Green
  • Methylprednisolone
Topics
  • Adult
  • Coloring Agents (administration & dosage)
  • Computed Tomography Angiography
  • Female
  • Fluorescein Angiography
  • Follow-Up Studies
  • Glucocorticoids (therapeutic use)
  • Humans
  • Indocyanine Green (administration & dosage)
  • Male
  • Methylprednisolone (therapeutic use)
  • Multifocal Choroiditis (diagnosis, drug therapy, physiopathology)
  • Retrospective Studies
  • Scotoma (diagnosis, drug therapy, physiopathology)
  • Tomography, Optical Coherence
  • Treatment Outcome
  • Visual Acuity (physiology)
  • Visual Fields (physiology)
  • White Dot Syndromes (diagnosis, drug therapy, physiopathology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: